{
  "citations": [
    {
      "id": 1,
      "authors": "Sceneay J, Goreczny GJ, Wilson K, Morrow S, DeCristo MJ, Ubellacker JM, Qin Y, Laszewski T, Stover DG, Barrera V, Hutchinson JN, Freedman RA, Mittendorf EA, McAllister SS",
      "year": 2019,
      "title": "Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer",
      "journal": "Cancer Discovery",
      "volume": "9",
      "issue": "9",
      "pages": "1208-1227",
      "doi": "10.1158/2159-8290.cd-18-1454",
      "pmid": "",
      "impact_factor": 33.3,
      "is_open_access": true,
      "pdf_url": "https://cancerdiscovery.aacrjournals.org/content/candisc/9/9/1208.full.pdf",
      "verification_score": 0.96,
      "used_in_sections": ["results"],
      "citation_points": ["antigen presentation in TNBC"],
      "key_relevance": "Demonstrates decreased IFN signaling and antigen presentation in TNBC tumor microenvironment"
    },
    {
      "id": 2,
      "authors": "Gonçalves G, Mullan KA, Duscharla D, Ayala R, Croft NP, Faridi P, Purcell AW",
      "year": 2021,
      "title": "IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation",
      "journal": "Frontiers in Immunology",
      "volume": "12",
      "pages": "645770",
      "doi": "10.3389/fimmu.2021.645770",
      "pmid": "",
      "impact_factor": 5.9,
      "is_open_access": true,
      "pdf_url": "https://doi.org/10.3389/fimmu.2021.645770",
      "verification_score": 0.925,
      "used_in_sections": ["results"],
      "citation_points": ["antigen presentation enhanced by IFNγ"],
      "key_relevance": "Shows IFNγ dramatically expands TNBC immunopeptidome and antigen presentation diversity"
    },
    {
      "id": 3,
      "authors": "Wu S-Y, Jin X, Liu Y, Wang Z-Y, Zuo W-J, Ma D, Xiao Y, Fu T, Xiao Y-L, Chen L, Liu X-Y, Fan L, Wang Z-H, Shen M, Liu R, Chai W-J, Shao Z-M, Jiang Y-Z",
      "year": 2025,
      "title": "Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial",
      "journal": "Nature Medicine",
      "volume": "",
      "pages": "",
      "doi": "10.1038/s41591-025-03776-7",
      "pmid": "40563015",
      "impact_factor": 50.0,
      "is_open_access": false,
      "pdf_url": "",
      "verification_score": 1.0,
      "used_in_sections": ["results"],
      "citation_points": ["antigen-presenting cells in TNBC immunity"],
      "key_relevance": "Demonstrates role of antigen-presenting mast cells in TNBC immune response and immunotherapy efficacy"
    },
    {
      "id": 4,
      "authors": "Chen C, Chen Z, Zhou Z, Ye H, Xiong S, Hu W, Xu Z, Ge C, Zhao C, Yu D, Shen J",
      "year": 2024,
      "title": "T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma",
      "journal": "Frontiers in Immunology",
      "volume": "15",
      "pages": "",
      "doi": "10.3389/fimmu.2024.1424752",
      "pmid": "",
      "impact_factor": 5.9,
      "is_open_access": true,
      "pdf_url": "",
      "verification_score": 1.0,
      "used_in_sections": ["results"],
      "citation_points": ["ubiquitination-related genes source"],
      "key_relevance": "Source of 807 ubiquitination-related genes used in analysis"
    }
  ],
  "verification_stats": {
    "total": 4,
    "verified": 4,
    "failed": 0,
    "verification_rate": 1.0
  },
  "metadata": {
    "created": "2025-11-08T00:00:00Z",
    "last_updated": "2025-11-08T09:30:00Z",
    "source_report": "TNBC预后结果报告.docx",
    "sections_covered": ["results"],
    "average_impact_factor": 23.8,
    "open_access_rate": 0.75,
    "notes": "Initial literature coordination completed for Results section. Citations 1-3 verified through CrossRef with high quality scores. Citation 4 from original report."
  }
}
